story of the week
Lubiprostone in Patients With NAFLD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Gastroenterology & Hepatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Lubiprostone in Patients With Non-Alcoholic Fatty Liver Disease: A Randomised, Double-Blind, Placebo-Controlled, Phase 2a Trial
Lancet Gastroenterol Hepatol 2020 Aug 14;[EPub Ahead of Print], T Kessoku, K Imajo, T Kobayashi, A Ozaki, M Iwaki, Y Honda, T Kato, Y Ogawa, W Tomeno, S Kato, T Higurashi, M Yoneda, H Kirikoshi, K Kubota, M Taguri, T Yamanaka, H Usuda, K Wada, N Kobayashi, S Saito, A NakajimaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.